Detalles de la búsqueda
1.
Application of the Statistical Method to Convert Published PASI 50/75/90/100 into Absolute PASI Response Rate in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab Based on Data from the Two Pivotal Phase 3 Studies reSURFACE 1 and reSURFACE 2.
Dermatology
; 238(5): 910-918, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35168231
2.
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Pain Med
; 22(4): 861-874, 2021 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33561282
3.
Individuals at risk for severe COVID-19 in whom ritonavir-containing therapies are contraindicated or may lead to interactions with concomitant medications: a retrospective analysis of German health insurance claims data.
Drugs Context
; 122023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415918
4.
Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?
Expert Rev Clin Pharmacol
; 15(4): 415-431, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35679523
5.
Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
J Clin Med
; 11(6)2022 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35329979
6.
Effects of Sativexâ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.
Mult Scler Relat Disord
; 68: 104173, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174323
Resultados
1 -
6
de 6
1
Próxima >
>>